26 jan: Villa Joy - dansk konceptbolig med verdensinspiration og potentia..
02 feb: Stort behov for mini-MBA i bestyrelsesuddannelse
28-01-2010 08:02:00

Preliminary Annual Accounts / Fourth Quarter Report 2009

This information is subject of the disclosure requirements acc. to §5-12 vphl

(Norwegian Securities Trading Act)

Rieber & Søn's operating profit (EBIT) in the fourth quarter totalled NOK 185m

(122m), while the figure for the year was NOK 424m (356m). EPS in the fourth

quarter stood at  NOK 1.52  (0.82) and NOK 3.32 (2.46) for the year.

Sales in the fourth quarter came to NOK 1 256m (1 377m), while the figure for

the year was NOK 4 967m (4 997m). Structural effects had a negative effect on

sales, reducing the performance by 1.6% in the fourth quarter, and by 0.6% for

the year. Currency conversion effects reduced sales in the fourth quarter by

4.7% and by 0.4% for the year. Organic growth stood at -2.4% in the fourth

quarter, while the increase for the year was 0.4%.

The gross margin in the fourth quarter rose to 59.2% (57.1%) and to 56.7%

(56,0%) for the year. The Group had good cost control in the fourth quarter and

payroll and operating costs were down 8% at NOK 569m, while the figure for the

year was 1% lower at NOK 2 218m. The EBITDA margin for the fourth quarter was

13,9% (12.1%) and 12.1% (11.2%) for the year. The corresponding figures for

 EBIT margin were 14.7% (8.9%) and 8.5% (7.1%), respectively.

The operating profit in the fourth quarter was positively affected by one-off

effects which contributed NOK 61m. This was the net effect of income of NOK 77m

from the sale of the  Sopps brand and the marine ingredients line in Arna, and

costs of NOK 16m related to the write-down of the production plant for Anja Cake

in Poland and transaction costs for the acquisition of Gellwe which was not

approved by the Polish competition authorities.  The operating profit for the

year was positively affected by one-off effects totalling NOK 32m. The Group's

core activities exclusive one-off items provided EPS of NOK 3.09 for the year,

which was 30% up on 2008.

The return on capital employed was 22.7% (14.1%) in the fourth quarters and

12.8% (10.9%) for the year.

In line with the Group's dividend policy, the Board will ask the AGM to approve

a dividend of NOK 2.00 per share. Together, this represents a 60% increase in

the dividend compared with the previous year and a dividend ratio of 60%.

"Our Future"

"Our Future" is aimed at achieving lasting improvements in results of NOK 400m

in 2012. The extra consumption of resources of a one-time nature in order to

realise these improvements is estimated to cost NOK 125m. The programme is

progressing as planned.

In the fourth quarter, the net effect of improvements in purchasing, production

and marketing under the "Our Future" platform totalled NOK 35m and comprised

positive effects of NOK 44m in the fourth quarter and implementation costs of

NOK 9m. The accumulated total of the positive, lasting effects in the first 12

months was NOK 96m, while implementation costs in the same period came to NOK

47m.

The aim to improve Group profitability was achieved in line with the plans for

2009. Through good cost control and the implementation of efficiency programmes

which provide lasting improvements, a sound basis has been laid for further

growth in profitability.

Bergen, 27 January 2010

Board of Directors of Rieber & Søn ASA

[HUG#1377906]

4Q Quarter Report 2009 : http://hugin.info/121/R/1377906/338577.pdf

4Q Presentation 2009: http://hugin.info/121/R/1377906/338578.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
26 jul
 
Pouli,   Forum er i den grad domineret af børn, studerende, ludomaner, buffet-wannabees and what hav..
24
28 jul
GEN
Der er lidt nyt fra Morphosys angående deres CD38 antistof - det lader heldigvis til at gå lidt lang..
17
30 jul
 
Jeg er helt vild med vendingen "og investere mine penge i aktier ud fra en strategi jeg mener vil sl..
14
29 jul
FING-B
XO/Sologstrand, Mackeith, Vildum, Swiftnick og andre FING-skeptikere   1) Er vi enige i, at markedet..
13
28 jul
 
Dejligt at der er nogen som kan svare "sobert" på et stillet spørgsmål.   Svaret kan indeholde ironi..
12
29 jul
BIOPOR
I er tydeligvis enormt begavede og succesfulde alle tre. Men kunne det være muligt for jer at måle j..
10
27 jul
 
Jeg har opdateret mine udbyttelister med tilbagekøb.   http://www.proinvestor.com/boards/69564/    
10
00:37
GEN
Rygterne siger At den hemmelige partner er Gilead. De er jo et af vardens største biotekselskaber de..
9
28 jul
VELO
28/07/2014 08:30:00 - OMX Copenhagen, News     VELO: Veloxis Pharmaceuticals A/S - Envarsus ® får ..
9
27 jul
BIOPOR
Alpe, det jeg skriver, skal absolut ikke ses som en meget udenoms forklaring.   men, trist du kun fo..
8

Novo: Tyske myndigheder ser ikke fordele ved Tresiba - NY

01-08-2014 13:47:20
Novo Nordisk er løbet ind i et nederlag i Tyskland.De tyske sundhedsmyndigheders rådgivende institut (IQWIG) er fredag kommet med en rapport, hvor det konkluder..

Mærsk: Vigtigt rateindeks vender kurven og stiger

01-08-2014 11:23:32
Det vigtige indeks over containerfragtrater, SCFI-indekset, har efter flere ugers fald vendt udviklingen og er steget 12,7 pct. i denne uge.Indekset, som viser ..

Genmab/Nordea: Arzerra-studier underbygger positiv holdning

01-08-2014 08:42:57
Genmab og partneren Glaxosmithkline offentliggjorde sent torsdag positive interimresultater med kræftmidlet Arzerra.Den foreløbige analyse, foretaget af en uafh..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/middag: Giftig cocktail trækker ned
2
Aktier/tendens: Faldene vil ebbe ud
3
Aktier/Nordnet: Private køber Pandora og Vestas
4
Europa/aktier: Adidas i største fald i 15 år
5
Torsdagens aktier: Bredt fald anført af Pandora og Carlsberg
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
1. august 2014 15:54:22
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140731.2 - EUROWEB7 - 2014-08-01 15:54:22 - 2014-08-01 15:54:22 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x